Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A(3) adenosine receptor antagonists.

C E Müller1

  • 1Pharmaceutical Institute, University of Bonn, Germany. christa.mueller@uni-bonn.de

Mini Reviews in Medicinal Chemistry
|October 9, 2002
PubMed
Summary

Researchers have developed potent antagonists for the human A(3) adenosine receptor (AR), showing promise for treating inflammatory conditions. However, effective rodent A(3) AR antagonists and water-soluble options are still needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical composition and physical characteristics of faeces in horses with and without free faecal liquid - two case-control studies.

BMC veterinary research·2022
Same author

Hippocampal synaptic dysfunction in the SOD1<sup>G93A</sup> mouse model of Amyotrophic Lateral Sclerosis: Reversal by adenosine A<sub>2A</sub>R blockade.

Neuropharmacology·2020
Same author

Caffeine modulates voluntary alcohol intake in mice depending on the access conditions: Involvement of adenosine receptors and the role of individual differences.

Pharmacology, biochemistry, and behavior·2019
Same author

Anti-inflammatory effect of a novel locally acting A<sub>2A</sub> receptor agonist in a rat model of oxazolone-induced colitis.

Purinergic signalling·2017
Same author

Contribution of platelet P2Y<sub>12</sub> receptors to chronic Complete Freund's adjuvant-induced inflammatory pain.

Journal of thrombosis and haemostasis : JTH·2017
Same author

A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Molecular psychiatry·2015

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • The human A(3) adenosine receptor (AR) is a key target for therapeutic intervention.
  • Significant progress has been made in developing selective antagonists for the human A(3) AR.
  • Existing antagonists primarily target the human receptor, with a lack of options for rodent models.

Purpose of the Study:

  • To review the development of potent and selective antagonists for the human A(3) adenosine receptor.
  • To highlight the chemical diversity of developed A(3) AR antagonists.
  • To identify current limitations and future directions in A(3) AR antagonist research.

Main Methods:

  • Literature review of published studies on A(3) adenosine receptor antagonists.
  • Categorization of antagonists based on chemical structure (tricyclic, bicyclic, monocyclic).
  • Analysis of selectivity, potency, and physicochemical properties (lipophilicity, solubility).

Main Results:

  • Development of various potent and selective human A(3) AR antagonists, including triazoloquinazoline, pyrazolo-triazolopyridine, imidazopurinone, triazoloquinoxaline, pyrazoloquinoline, isoquinoline, quinazoline, dihydropyridine, and pyridine derivatives.
  • Absence of potent and selective antagonists for rodent A(3) ARs.
  • Most developed A(3) AR antagonists are highly lipophilic with poor water solubility.

Conclusions:

  • Numerous potent and selective antagonists for the human A(3) AR have been synthesized.
  • Challenges remain in developing rodent A(3) AR antagonists and improving the water solubility of existing compounds.
  • A(3) AR antagonists hold therapeutic potential for inflammatory diseases, asthma, stroke, and glaucoma.

Related Experiment Videos